[{"AccountsPayableCurrent_0_Q1_USD":59200000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTaxParent_1_Q1_USD":0.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent_1_Q1_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-4200000.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":0.0,"OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentBeforeTaxPortionAttributableToParent_1_Q1_USD":0.0,"OtherAssetsNoncurrent_0_Q1_USD":11300000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":36200000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":45100000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":50100000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":15100000.0,"OperatingIncomeLoss_1_Q1_USD":-12400000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent_1_Q1_USD":0.0,"NumberOfReportableSegments_1_Q1_segment":1.0,"NetIncomeLoss_1_Q1_USD":-7600000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-3300000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-5700000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-200000.0,"LossContingencyAccrualAtCarryingValue_0_Q1_USD":22200000.0,"LongTermDebt_0_Q1_USD":175000000.0,"LiabilitiesCurrent_0_Q1_USD":154600000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":1648800000.0,"Liabilities_0_Q1_USD":396200000.0,"InvestmentIncomeInterest_1_Q1_USD":0.0,"InventoryWorkInProcess_0_Q1_USD":32700000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-4200000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansTax_1_Q1_USD":0.0,"OtherInventorySupplies_0_Q1_USD":6300000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":0.0,"TreasuryStockValue_0_Q1_USD":9800000.0,"TaxesPayableCurrent_0_Q1_USD":3400000.0,"StockholdersEquity_0_Q1_USD":1252600000.0,"ShareBasedCompensation_1_Q1_USD":3100000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":73400000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":180700000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-323100000.0,"RestructuringCharges_1_Q1_USD":1100000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":8300000.0,"RepaymentsOfLinesOfCredit_1_Q1_USD":5000000.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":-400000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":173400000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":291900000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":4800000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":18300000.0,"PreferredStockValue_0_Q1_USD":0.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"PreferredStockSharesAuthorized_0_Q1_shares":20000000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PaymentsToAcquireProductiveAssets_1_Q1_USD":5700000.0,"OtherSundryLiabilitiesNoncurrent_0_Q1_USD":4900000.0,"OtherOperatingIncomeExpenseNet_1_Q1_USD":-22000000.0,"OtherOperatingActivitiesCashFlowStatement_1_Q1_USD":-5900000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":10900000.0,"InventoryRawMaterials_0_Q1_USD":49300000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":48000000.0,"InventoryNet_0_Q1_USD":165200000.0,"InventoryGross_0_Q1_USD":171700000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":15400000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":89400000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-11800000.0,"CommonStockValue_0_Q1_USD":500000.0,"CommonStockSharesOutstanding_0_Q1_shares":48059819.0,"CommonStockSharesAuthorized_0_Q1_shares":300000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"CommitmentsAndContingencies_0_Q1_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-11400000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":100100000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":100100000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":5600000.0,"AssetsCurrent_0_Q1_USD":447900000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":1100000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":4200000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3100000.0,"AdditionalPaidInCapital_0_Q1_USD":1617300000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-32300000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":118500000.0,"AccruedSalariesCurrent_0_Q1_USD":21300000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":80300000.0,"AccruedIncomeTaxesNoncurrent_0_Q1_USD":400000.0,"AccountsReceivableNet_0_Q1_USD":105300000.0,"AccountsReceivableGrossCurrent_0_Q1_USD":109500000.0,"Assets_0_Q1_USD":1648800000.0,"Depreciation_1_Q1_USD":5500000.0,"DepreciationDepletionAndAmortization_1_Q1_USD":9700000.0,"EarningsPerShareBasic_1_Q1_USD":-0.16,"InventoryFinishedGoods_0_Q1_USD":83400000.0,"InterestExpense_1_Q1_USD":800000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":153600000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-500000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-2800000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-2000000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":-2200000.0,"IncreaseDecreaseInAccountsPayableTrade_1_Q1_USD":-6200000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-5600000.0,"IncomeTaxesReceivable_0_Q1_USD":59000000.0,"IncomeLossAttributableToParent_1_Q1_USD":-13200000.0,"GrossProfit_1_Q1_USD":91300000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":400000.0,"Goodwill_0_Q1_USD":802100000.0,"GainLossOnDispositionOfAssets1_1_Q1_USD":-100000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":153600000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":433700000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_0_Q1_USD":15200000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_0_Q1_USD":15100000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0_Q1_USD":14600000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_0_Q1_USD":12300000.0,"FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_0_Q1_USD":16100000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":280100000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-2200000.0,"EarningsPerShareDiluted_1_Q1_USD":-0.16,"InventoryLIFOReserve_0_Q1_USD":6500000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":48000000.0,"Ticker":"AVNS","CIK":"1606498","name":"AVANOS MEDICAL, INC.","OfficialName":"Avanos Medical Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1515595188.0","Country":"United States","Sector":"Health Care","Industry":"Industrial Specialties","Market":"NYSE","SP500":"nan","filed":"20210507"}]